Please ensure Javascript is enabled for purposes of website accessibility

Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$51.45 $4.24 9.0%
Price as of February 24, 2021, 9:00 p.m. EST View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Interactive Chart


News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings